Sun Pharma plans to refinance bridge loans into long-term debt within 18 months after its Organon deal, while prioritising deleveraging through strong cash flows
Source :- Companies Read More
Sun Pharma plans to refinance bridge loans into long-term debt within 18 months after its Organon deal, while prioritising deleveraging through strong cash flows